Study Stopped
Low accrual
Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients
2 other identifiers
interventional
9
1 country
1
Brief Summary
This project's overall goal is to test the feasibility, acceptability and efficacy of two coach-assisted, computer-based, cognitive- behavioral therapy (C-CBT) interventions in treating depression and anxiety in adolescent and young adult cancer survivors. The two coach-assisted interventions will be compared to the standard C-CBT intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 23, 2021
CompletedFirst Posted
Study publicly available on registry
February 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 3, 2021
CompletedJanuary 10, 2022
December 1, 2021
8 months
February 23, 2021
December 16, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Rate of C-CBT completion
Percentage of participants in each arm who complete at least 6 out of 8 sessions, as measured by online service usage data.
10 weeks
Percentage of participants who confirm acceptability of the intervention during interviews
Participants will be interviewed about their perceptions regarding the delivery format, treatment content, and other treatment related factors. Qualitative interviews will be transcribed by research staff and coded using thematic content analysis and axial coding. Qualitative data will be reviewed iteratively until saturation is reached, that is when no new information seems to emerge during coding. Emergence or non-emergence of acceptability theme will be assessed. Findings will be descriptive and will include the percentage of participants who confirm acceptability.
10 weeks
Secondary Outcomes (5)
Change in level of depression from baseline to end of intervention
10 weeks
Change in level of anxiety from baseline to end of intervention
10 weeks
Change in level of distress from baseline to end of intervention
10 weeks
Change in level of self-efficacy from baseline to end of intervention
10 weeks
Change in level of involvement and participation in health care from baseline to end of intervention
10 weeks
Study Arms (3)
Coach-assisted C-CBT with BtB
EXPERIMENTALParticipants will receive coach- assisted Beating the Blues (BtB), a C- CBT program, which contains 8 weekly sessions. A coach will provide between session support throughout the 8 sessions.
Coach-assisted animated C-CBT with EMW
ACTIVE COMPARATORParticipants will receive coach- assisted Entertain Me Well (EMW), an animated C-CBT program, which contains 8 weekly sessions. A coach will provide between session support throughout the 8 sessions.
Standard stand-alone C-CBT with BtB
ACTIVE COMPARATORParticipants will use the stand-alone BtB for 8 weekly sessions, without coach assistance.
Interventions
Beating the Blues (BtB) is a C-CBT intervention with 8 weekly sessions to be completed within 10 weeks.
Entertain Me Well (EMW) is is a C-CBT intervention with 8 weekly sessions to be completed within 10 weeks.
A coach will spend approximately 5-10 minutes after each session with the patient to link the C-CBT content with patient's disease specific experiences and to motivate them to continue the program. They will also spend approximately 5 minutes between sessions to motivate a patient to complete assignments and to remind them about starting the next session on time.
Eligibility Criteria
You may qualify if:
- Cancer survivor, either receiving active treatment or completed cancer treatment
- Experiencing depression and anxiety as measured by PHQ-9 or GAD-7
You may not qualify if:
- Severe medical or mental condition (e.g. suicidal ideation)
- Medical condition that prevents patients from operating a computer or tablet
- Receiving end-of-life care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anao Zhang, Ph.D.
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2021
First Posted
February 26, 2021
Study Start
November 30, 2020
Primary Completion
August 3, 2021
Study Completion
August 3, 2021
Last Updated
January 10, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share